Brain iron and ferritin in Parkinson's and Alzheimer's diseases
- PMID: 2078310
- DOI: 10.1007/BF02252926
Brain iron and ferritin in Parkinson's and Alzheimer's diseases
Abstract
Semiquantitative histological evaluation of brain iron and ferritin in Parkinson's (PD) and Alzheimer's disease (DAT) have been performed in paraffin sections of brain regions which included frontal cortex, hippocampus, basal ganglia and brain stem. The results indicate a significant selective increase of Fe3+ and ferritin in substantia nigra zona compacta but not in zona reticulata of Parkinsonian brains, confirming the biochemical estimation of iron. No such changes were observed in the same regions of DAT brains. The increase of iron is evident in astrocytes, macrophages, reactive microglia and non-pigmented neurons, and in damaged areas devoid of pigmented neurons. In substantia nigra of PD and PD/DAT, strong ferritin reactivity was also associated with proliferated microglia. A faint iron staining was seen occasionally in peripheral halo of Lewy bodies. By contrast, in DAT and PD/DAT, strong ferritin immunoreactivity was observed in and around senile plaques and neurofibrillary tangles. The interrelationship between selective increase of iron and ferritin in PD requires further investigation, because both changes could participate in the induction of oxidative stress and neuronal death, due to their ability to promote formation of oxygen radicals.
Similar articles
-
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.J Neurochem. 1991 Mar;56(3):978-82. doi: 10.1111/j.1471-4159.1991.tb02017.x. J Neurochem. 1991. PMID: 1704426
-
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.J Neurosci Res. 1992 Jan;31(1):75-83. doi: 10.1002/jnr.490310111. J Neurosci Res. 1992. PMID: 1613823
-
Complex I, iron, and ferritin in Parkinson's disease substantia nigra.Ann Neurol. 1994 Dec;36(6):876-81. doi: 10.1002/ana.410360612. Ann Neurol. 1994. PMID: 7998774
-
Nuclear microscope analysis in Alzheimer's and Parkinson's disease: A review.Cell Mol Biol (Noisy-le-grand). 1996 Feb;42(1):17-26. Cell Mol Biol (Noisy-le-grand). 1996. PMID: 8833663 Review.
-
The role of iron in senescence of dopaminergic neurons in Parkinson's disease.J Neural Transm Suppl. 1993;40:57-67. J Neural Transm Suppl. 1993. PMID: 8294901 Review.
Cited by
-
Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study.Drug Des Devel Ther. 2014 Dec 18;9:187-98. doi: 10.2147/DDDT.S72794. eCollection 2015. Drug Des Devel Ther. 2014. PMID: 25565772 Free PMC article.
-
Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.Acta Neuropathol Commun. 2021 Mar 22;9(1):47. doi: 10.1186/s40478-021-01145-2. Acta Neuropathol Commun. 2021. PMID: 33752749 Free PMC article.
-
Increased iron content in the putamen of patients with striatonigral degeneration.Acta Neuropathol. 1992;84(3):328-30. doi: 10.1007/BF00227827. Acta Neuropathol. 1992. PMID: 1414283
-
Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues.Acta Neuropathol. 1992;84(5):538-44. doi: 10.1007/BF00304473. Acta Neuropathol. 1992. PMID: 1462766
-
The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease.Front Neurosci. 2018 Dec 20;12:981. doi: 10.3389/fnins.2018.00981. eCollection 2018. Front Neurosci. 2018. PMID: 30618597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical